Identification of Potential Barriers to Timely Access to Pediatric Hearing Aids

Abstract

IMPORTANCE Despite various barriers identified to early pediatric access to cochlear implantation, barriers to timely access to pediatric hearing aids are not well characterized.OBJECTIVE To identify socioeconomic, demographic, and clinical factors that may be associated with pediatric access to hearing aids. DESIGN, SETTING, AND PARTICIPANTSThis retrospective cohort study included 90 patients aged 1 to 15 years who were referred for auditory brainstem response (ABR) testing and evaluation for hearing aids at a single tertiary care academic medical center from March 2004 to July 2018. Children who did not receive both ABR testing and hearing aids at the same center were excluded from analysis.MAIN OUTCOMES AND MEASURES Associations of insurance type (private vs public), race/ethnicity (white vs other), primary language (English vs other), cause of hearing loss (complex vs not complex), zip code, hearing aid manufacturer, and severity of hearing loss (in decibels) with the duration of intervals from newborn hearing screening to ABR testing, from ABR testing to ordering of hearing aids, and from ABR testing to dispensing of hearing aids. RESULTSOf the 90 patients, mean (SD) age was 5.6 (3.7) years, 56% were female, and 77 (86%) were non-Hispanic. Results of χ 2 tests indicated significant assocations existed between public insurance and race/ethnicity and between public insurance and primary language other than English. Variables associated with the interval from newborn hearing screening to ABR testing included insurance type (mean difference, 7.4 months; 95% CI, 2.6-12.2 months) and race/ethnicity (mean difference, 6.9 months; 95% CI, 2.7-11.1 months). Increased delays between birth and a child's first ABR test were associated with public insurance (mean difference, 6.0 months; 95% CI, 1.8-10.2 months) and race/ethnicity other than white (mean difference, 6.0 months; 95% CI, 2.3-9.7 months). The mean time from birth to initial ABR testing was a mean of 6 months longer for patients from non-English-speaking families than for those from English-speaking families (mean [SD] interval, 14.9 [16.3] months vs 9.0 [8.5] months), although the difference was not statistically significant. Severity of hearing loss was associated with a decrease in the interval from ABR testing to ordering of hearing aids after accounting for other potential barriers (odds ratio, 0.6; 95% CI, 0.4-0.9). Zip code and complexity of the child's medical condition did not appear to be associated with timely access to pediatric hearing aids.CONCLUSIONS AND RELEVANCE This study's findings suggest that insurance type, race/ethnicity, and primary language may be barriers associated with pediatric access to hearing aids, with the greatest difference observed in time to initial ABR testing. Clinical severity of hearing loss appeared to be associated with a significant decrease in time from ABR testing to ordering of hearing aids. Greater efforts to assist parents with ABR testing and coordination of follow-up may help improve access for other at-risk ch...

Relationship between Insurance Type and Delays in Tympanostomy Tube Placement

“…Black patients were more likely both to reschedule tympanostomy tube placement and experience cancelation of tympanostomy tube placement. This is consistent with other studies, including hearing aid access and ABR testing, 14 as well as cochlear implantation. 22 Reasons for delays in care between different races/ethnicities may include difficulty accepting the diagnosis, 23 language barriers or cultural beliefs, 24 and socioeconomic factors that impact ability to attend scheduled surgical appointments.…”

“…The impact of insurance type on delay to surgical care has been shown for various otolaryngologic surgeries, including upper airway stimulation, 13 adenotonsillectomy, 6 auditory brainstem response testing, 14 cochlear implantation, 15 and head and neck cancer treatment, 16 with publicly insured patients demonstrating higher rates of delay. Patients in our study who were insured by Medicaid at the time of their clinic visits had 40% higher odds of rescheduling the surgery than privately insured patients.…”

Development and validation of DeciBHAL-US: A novel microsimulation model of hearing loss across the lifespan in the United States

“…For pediatric hearing aid use, we incorporated time to uptake data to inform yearly probabilities of acquiring hearing aids (age 1 year: mean=15.8 months, SD=16.8 months; ages 2–5 years: 31.68 months, SD=18.32 months). 46 , 47 We assumed a linear decline in hearing aid acquisition from age 5 years to adulthood. Combined with a discontinuation rate of 3%/year, we projected the yearly proportion of children with aidable hearing loss (defined as PTA≥25 dB in the better ear) using hearing aids.…”

Tele-Audiology: Current State and Future Directions

“…With respect to hearing healthcare specifically, previous studies have demonstrated significantly higher rates of hearing aid use among White older adults as compared to minority groups (28.6–35.4% of White older adults vs. 10–17.1% of minorities) ( 30 , 32 , 34 ). In pediatric patients, Zhang et al ( 35 ) found a relationship between race/ethnicity and the time delay between a failed newborn hearing screening and initial auditory brainstem response (ABR) testing. The mean interval for White patients was 6.3 months [standard deviation (SD): 5.6 months] compared to 12.3 months (SD: 11.8 months) for racial/ethnic minority patients.…”

“…Thus, it begs the question-what most contributes to the lack of care, and how can this be improved? While reasons vary from community-to-community and from individualto-individual, common factors include cost of services (18)(19)(20), a shortage of clinical providers/specialized services (21)(22)(23)(24)(25)(26), inconvenience of travel (24,27), communication barriers (28,29), and racial/ethnic disparities (30)(31)(32)(33)(34)(35). The COVID-19 pandemic, with its associated lockdowns and social distancing requirements, led to mass disruption in the delivery of healthcare services worldwide.…”